LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial. Lancet Diabetes Endocrinol 2018; 6: 870-878.
Published: 27th February 2019
Authors: Game F, Jeffcoate W, Tarnow L, Jacobsen JL, Whitham DJ, Harrison EF et al.
Weekly application of the patch dressing improved ulcer healing at 20 weeks from 22 to 34 per cent (P=0.0235) in this study that included 269 patients with a diabetic foot ulcer. There were no device-related adverse events.Pubmed Link
You may also be interested in
Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol 2018; 6: 186–196.
Authors: Edmonds M, Lazaro-Martinez JL, Alfayate-Garcia JM, Martini J, Petit J-M, Rayman G et al.
Hyperbaric oxygen therapy in the treatment of ischemic lower- extremity ulcers in patients with diabetes: Results of the DAMO2CLES multicenter randomized clinical trial. Diabetes Care 2018; 41: 112-119.
Authors: Santema KT, Stoekenbroek RM, Koelemay MJ, Reekers JA, van Dortmont LM, Oomen A et al.
Composite skin grafting with human acellular dermal matrix scaffold for treatment of diabetic foot ulcers: a randomized controlled trial. J Am Coll Surg 2016; 222: 1171–1179.
Authors: Hu Z, Zhu J, Cao X, Chan C, Li S, Guo D et al.
Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review. Eur J Vasc Endovasc Surg 2014; 47: 647-655.
Authors: Stoekenbroek RM, Santema TB, Legemate DA, Ubbink DT, van den Brink A, Koelemay MJW et al.
Negative pressure wound therapy: systematic review on effectiveness and safety. Eur J Vasc Endovasc Surg 2008; 36: 438-448.
Authors: Vikatmaa P, Juutilainen V, Kuukasjarvi P, Malmivaara A.
Systematic review of dressings and topical agents for surgical wounds healing by secondary intention. Br J Surg 2005; 92: 665-672.
Authors: Vermeulen H, Ubbink DT, Goossens A, de Vos R, Legemate DA.
Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005; 366: 1695¿1703.
Authors: Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA. et al.
Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005; 366: 1704¿1710.
Authors: Armstrong DG, Lavery LA for the Diabetic Foot Study Consortium.
The role of hyperbaric oxygen in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial Eur J Vasc Endovasc Surg 2003; 25: 513-8.
Authors: Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM et al et al.
A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds Ann Vasc Surg 2003; 17: 645?649.
Authors: Eginton MT, Brown KR, Seabrook GR, Towne JB, Cambria RA.
Effect of therapeutic footwear on foot reulceration in patients with diabetes. JAMA 2002; 287: 2552-8.
Authors: Reiber GE, Smith DG, Wallace C, Sullivan K, Hayes S, Vath C et al. et al.
A randomized controlled trial of Promogram (a collage/oxidised regenerated cellulose dressing) vs. standard treatment in the management of diabetic foot ulcers. Arch Surg 2002; 137: 822-7.
Authors: Veves A, Sheehan P, Pham HT for the Promogram Diabetic Foot Ulcer Study.